MIT Report: IBM Watson, machine-learning plays “ overhyped ”

IBM (NYSE:IBM) Watson Health, and other machine-learning company's immediate impact on healthcare may have been significantly overhyped, promoting a timeline  that it may not be able to reach, according to a new article from MIT's Technology Review. The fault lies not with the company, however, but the complexity and relative unavailability of data that it and others machine-learning systems needs to "learn," according to the article. Machine learning processes require constant adjustments to internal processing routines to produce the highest possible percentage of correct answers to a set of problems, according to the article. This process works well with cases where it's easy to identify problems or solutions, such as malignancies in X-rays, but becomes exponentially har...

from MedWorm via o.lakala70 on Inoreader http://ift.tt/2tn2dMD
via IFTTT